+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

From
From
Alzheimer's Disease Treatment Market Report 2026 - Product Thumbnail Image

Alzheimer's Disease Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2026

  • Report
  • April 2026
  • 350 Pages
  • Global
From
From
From
From
From
From
From
Collaboration Deals in Pharmaceuticals 2020-2026 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2020-2026

  • Report
  • March 2026
  • 850 Pages
  • Global
From
Oral Antiepileptic Drug Market - Global Forecast 2025-2030 - Product Thumbnail Image

Oral Antiepileptic Drug Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
Cedar Pollen Allergy Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cedar Pollen Allergy Drug Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
Pediatric Neuroblastoma Treatment Market Report 2026 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator